---
title: "Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296440057.md"
description: "Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M"
datetime: "2026-08-20T05:46:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296440057.md)
  - [en](https://longbridge.com/en/news/296440057.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296440057.md)
generator: "portal-rs"
---

# Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M


### Related Stocks

- [INBS.US](https://longbridge.com/en/quote/INBS.US.md)

## Related News & Research

- [INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026](https://longbridge.com/en/news/296357255.md)
- [XORTX Therapeutics Inc. GAAP EPS of -$1.05](https://longbridge.com/en/news/296650983.md)
- [Aptorum Group GAAP EPS of -$1.60](https://longbridge.com/en/news/296654186.md)
- [ZK International GAAP EPS of -$0.89, revenue of $1M](https://longbridge.com/en/news/296649006.md)
- [Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook](https://longbridge.com/en/news/296058426.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**